A name reaches you. A colleague mentioned it, it appeared in a screen, it was in the news. You want to know whether it is worth buying.
"Is this a good stock" is unanswerable — good for whom, over what period, against what alternative. Asked that way, research becomes a search for reassurance, and reassurance is always available if you look for it.
The productive version is: what would have to be true for this to work, and how much of that can I actually check?
Here is an order for finding out.
Step one: what is it, exactly
Start with identity, because it is astonishing how often this is where the error is.
Open the instrument's page from the stocks list or through search. Confirm the full company name, not the ticker that sounded right. Similar names and similar tickers cause real mistakes, and they cause them at the moment of ordering rather than the moment of researching.
While there, establish the basics: what the company does, which sector it sits in, and its rough size. A company you cannot describe in a sentence is one you cannot form a view on.
Step two: the current reading
Live quote, day's range, and where the price sits against its recent history.
The purpose is not to judge whether the price is "cheap". It is to establish context for everything that follows. A stock near the top of its recent range and one near the bottom are different situations, and the news you read next will land differently depending on which you are in.
Check the timestamp and market state. A quote from a closed market is a closing price, not a current one. Trading on a stale number is a specific and avoidable error, which is why PocketX carries as-of times on its market data rather than presenting numbers without provenance.
Step three: the fundamentals, held lightly
The instrument page carries company fundamentals. Read them, and read them for direction and consistency rather than for a verdict.
What you are looking for is whether the picture is coherent. Are revenues and profits moving together? Is the trend steady or erratic? Does anything look sharply out of line with the rest?
What you are not doing is computing a fair value from a few ratios and deciding the stock is undervalued. That calculation requires assumptions you do not have, and the answer will simply reflect whatever you assumed.
Fundamentals are best used to disqualify rather than to select. A company whose numbers are deteriorating consistently is a reason to stop. A company whose numbers look fine is not yet a reason to buy.
Step four: what has been happening
Now the news, and any research context available on the instrument.
Three questions:
- Has anything material happened recently? Results, a large order, a regulatory development, a change in management.
- Does it explain the price? If the stock has moved sharply and there is no visible cause, that is worth noting rather than ignoring.
- Is what I am reading a fact or an opinion? An announcement is a fact. An analyst's target is an opinion, and it should be weighted accordingly.
The news surface covers market and company news. Where research calls exist, how to read a research call covers what a call is actually claiming and what it is not.
Step five: the sector, for context
A stock's move frequently is not about the stock.
Check the heatmap or the relevant index. If the whole sector is up four per cent and your stock is up four and a half, you are looking at a sector event with a small company-specific component. That is a different thesis from a stock that rose alone.
This matters for sizing as much as for selection. If you already hold two names in the same sector, adding a third is not diversification — it is increasing one bet while feeling like you are spreading risk.
Step six: can I actually trade it?
The step people skip, and it disqualifies more candidates than any fundamental analysis.
Check the spread and the depth on the instrument page. A stock you can buy but not exit at a sensible price is not an opportunity, however attractive the story.
This applies with particular force to anything that surfaced from a screen sorted by percentage move. Thin counters produce large percentage changes on small orders, and the same thinness will be there when you want out. The screener guide covers why liquidity is the filter that is never optional.
Step seven: write the thesis and the exit
Before any order, two sentences.
Why this should work. One sentence, specific. "It is going up" is not a thesis. "Margins have improved for three consecutive quarters and the market appears to still be pricing the old margin structure" is a thesis — checkable, and capable of being wrong.
What would tell me I am wrong. A price level, a fundamental deterioration, a time limit. Written down, in advance.
If you cannot write the second sentence, do not place the trade. A position without a defined exit is not an investment decision; it is an open-ended commitment that will be resolved by emotion at a moment you did not choose. How to set a stop-loss covers where that level should come from.
Where the assistant fits
For anything the sequence leaves unresolved, the PocketX assistant answers plain-language questions from current market data and shows the instruments behind its answer.
Use it for the gaps: what a term means, what a company's recent readings are, what related instruments exist. Two boundaries: it is read-only — it explains, it does not act — and it does not give individualised investment advice. It is a faster route to evidence, not a substitute for the decision.
The checklist
- Identity — the right company, described in a sentence.
- Current reading — price, range, and the as-of time.
- Fundamentals — direction and coherence, not a verdict.
- News — material events, and fact separated from opinion.
- Sector — is this a stock story or a sector story?
- Tradeability — spread and depth, before anything else is decided.
- Thesis and exit — both written, before the order.
Most candidates fail somewhere in the first six. That is the checklist working. The purpose of research is mainly to eliminate, and a process that eliminates nothing is not research — it is a way of arriving at a decision you had already made.
If the name survives but today is not the day, put it on a watchlist and let it come to your price.